Qube Research & Technologies LTD Deciphera Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.58 - $17.36 $1.66 Million - $2.12 Million	122,296 Added 102.12%	242,056 $3.81 Million
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $444,880 - $727,826	44,004 Added 58.09%	119,760 $1.93 Million
Q3 2023 Nov 13, 2023	SELL	$12.46 - $15.48 $321,355 - $399,244	-25,791 Reduced 25.4%	75,756 $963,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $1.35 Million - $1.62 Million	101,547 New	101,547 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $634,243 - $813,198	42,710 Added 35.15%	164,226 $2.69 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $650,222 - $1.06 Million	52,522 Added 76.13%	121,516 $2.25 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $628,535 - $964,536	68,994 New	68,994 $907,000
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $178,373 - $368,097	-5,304 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $168,136 - $370,908	5,304 New	5,304 $330,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.